Canada Diabetes Market Report: 2026-2034

Canada Diabetes Market Report: 2026-2034

Report Format: PDF+Excel | Report ID: SR112025A681

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1 Overview
    4.2 Key Industry Trends
5   Diabetes Disease Overview
    5.1 What is Diabetes?
    5.2 Diabetes Diagnosis and Treatment
        5.2.1 Diagnosis
        5.2.2 Treatment
    5.3 Diabetes Complications
6   Canada Diabetes Epidemiology
    6.1 Diabetes Population and Prevalence Rates
    6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
    6.3 Population and Prevalence Rates by Region
    6.4 Population and Prevalence Rates by Gender
    6.5 Population and Prevalence Rates by Age Group
7   Canada Diabetes Market
    7.1 Market Overview 
    7.2 Market Performance
    7.3 Impact of COVID-19
    7.4 Market Forecast
    7.5 SWOT Analysis
        7.5.1 Overview
        7.5.2 Strengths
        7.5.3 Weaknesses
        7.5.4 Opportunities
        7.5.5 Threats
    7.6 Value Chain Analysis
    7.7 Porter’s Five Forces Analysis
        7.7.1 Overview
        7.7.2 Bargaining Power of Buyers
        7.7.3 Bargaining Power of Suppliers
        7.7.4 Degree of Competition
        7.7.5 Threat of New Entrants
        7.7.6 Threat of Substitutes
     7.8 Market Breakup by Segment
        7.8.1 Canada Oral Antidiabetics Market
            7.8.1.1 Historical Market Trends
            7.8.1.2 Market Breakup by Class
            7.8.1.3 Market Shares of Key Players
            7.8.1.4 Market Forecast
        7.8.2 Canada Insulin Market
            7.8.2.1 Historical Market Trends
            7.8.2.2 Market Breakup by Class
            7.8.2.3 Market Shares of Key Players
            7.8.2.4 Market Forecast
8   Competitive Landscape
    8.1 Competitive Structure
    8.2 Profiles of Key Players

List of Figures

Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %), 2025 & 2034
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: Canada: Total Number of Diabetes Patients (in 000), 2020-2025
Figure 6: Canada: Total Number of Diabetes Patients Forecast (in 000), 2026-2034
Figure 7: Canada (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2020-2025
Figure 8: Canada (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2026-2034
Figure 9: Canada (Urban & Rural): Total Number of Diabetes Patients (in 000), 2020-2025
Figure 10: Canada (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2026-2034
Figure 11: Canada (Male & Female): Total Number of Diabetes Patients (in 000), 2020-2025
Figure 12: Canada (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2026-2034
Figure 13: Canada: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2020-2025
Figure 14: Canada: Total Number of Diabetes Patients Forecast by Age Group (20-39), (40-59) & (60-79) (in 000), 2026-2034
Figure 15: Canada: Diabetes Drug Industry Overview
Figure 16: Canada: Diabetes Drug Market: Sales Value (in Million USD), 2020-2025
Figure 17: Canada: Diabetes Drug Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 18: Canada: Diabetes Drug Market: SWOT Analysis
Figure 19: Canada: Diabetes Drug Market: Value Chain Analysis
Figure 20: Canada: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: Canada: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2020-2025
Figure 22: Canada: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2026-2034
Figure 23: Canada: Oral Antidiabetics Market: Sales Value (in Million USD), 2020-2025
Figure 24: Canada: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2020 & 2025
Figure 25: Canada: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: Canada: Oral Antidiabetics Market: Sales Value (in Million USD), 2026-2034
Figure 27: Canada: Insulin Market: Sales Value (in Million USD), 2020-2025
Figure 28: Canada: Breakup of Insulin Market by Class (in %), 2020 & 2025
Figure 29: Canada: Insulin Market: Sales Share of Key Players (in %)
Figure 30: Canada: Insulin Market Forecast: Sales Value (in Million USD), 2026-2034

List of Tables

Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2025 and 2034
Table 3: Canada: Total Prevalence & Number of Diabetes Patients, 2020, 2025 & 2034
Table 4: Canada (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2020, 2025 & 2034
Table 5: Canada (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2020, 2025 & 2034
Table 6: Canada (Male & Female): Total Prevalence & Number of Diabetes Patients, 2020, 2025 & 2034
Table 7: Canada: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2020, 2025 & 2034
Table 8: Canada: Diabetes Drug Market: Competitive Structure

Canada Diabetes Market Report: 2026-2034
Purchase Options Year End
sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-201-971-6302

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials